Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2005
View Archived Issues
Neuroprotective effects of beta-lactam antibiotics
Read More
BMP-7 effective in preclinical models of Parkinson's disease and kidney injury
Read More
Teduglutide is a potential anti-mucositis therapeutic for chemotherapy patients
Read More
Parthenolide: a novel agent from a natural product with potent antileishmanial activity in vitro
Read More
GlobeImmune and MycoLogics enter agreement for antifungal vaccines
Read More
Phase II trial investigates alagebrium chloride for erectile dysfunction
Read More
DPP-IV inhibitor PSN-9301 enters phase II study
Read More
Phase II study evaluates recombinant microplasmin in vitreoretinal disorders
Read More
Positive preliminary phase III results for Sativex in severe cancer pain
Read More
Addex and Ortho-McNeil collaborate in anxiety, depression, schizophrenia
Read More
AN-152 enters clinical development
Read More
NIAID begins second phase I study of HIV vaccine
Read More
Not approvable letter for Marqibo
Read More
ID Biomedical commences development of vaccine against H5N1 influenza strain
Read More
Advanced Biotherapy completes pilot study in genital herpes
Read More
Adenosine Therapeutics enters collaboration agreement in asthma and diabetes
Read More
Vesicare available in U.S.
Read More
Roche patent covers adenosine A2A receptor ligands
Read More
Fujisawa and Wakunaga jointly report novel cephem antibiotics
Read More
Pfizer researchers describe androgen receptor antagonists
Read More
Protein tyrosine phosphatase PTP-1B inhibitors under study at Roche
Read More
MMP inhibitors for treatment of inflammatory conditions
Read More
Update on the antitumor effects of bortezomib in MM and non-Hodgkin's lymphoma
Read More
BMAP-28 reported to reduce lethality associated with staphylococcal sepsis in mice
Read More
OM-197-MP-AC induces maturation of dendritic cells in vitro
Read More
IRAK1 shows promise as a novel target in the treatment of atherosclerosis
Read More
R-130823, a p38 MAPK inhibitor, effective in models of rheumatoid arthritis
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe